Evidence map›Paper›PMID 36652557›Full record

ArticleCancer research2023

Active Remodeling of Capillary Endothelium via Cancer Cell-Derived MMP9 Promotes Metastatic Brain Colonization.

Matthia A Karreman, Alexander T Bauer, Gergely Solecki, Anna S Berghoff, Chanté D Mayer, Katharina Frey, Nils Hebach, Manuel J Feinauer, Nicole L Schieber, Cedric Tehranian and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. An MRI Atlas of Regional Brain Vulnerability to Metastatic Disease.medRxiv : the preprint server for health sciences · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Metastasis-promoting functions of myeloid cells.Cancer metastasis reviews · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 5 countries.

Matthia A KarremanNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0003-0074-5945
Alexander T BauerDepartment of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-3426-0073
Gergely SoleckiNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0003-0267-7341
Anna S BerghoffNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0001-9379-6797
Chanté D MayerNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0001-7885-6798
Katharina FreyNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0003-0639-7961
Nils HebachNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0003-1921-3244
Manuel J FeinauerNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0001-6459-1899
Nicole L SchieberCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Heidelberg, Germany.ORCID 0000-0002-3212-5057
Cedric TehranianClinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0003-1737-6103
Luc MercierNational Institute of Health and Medical Research (INSERM) UMR_S1109, Tumor Biomechanics, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.ORCID 0000-0002-5866-2547
Mahak SinghalEuropean Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0002-7303-9585
Varun VenkataramaniNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-2927-0886
Marc C SchubertDepartment of Functional Neuroanatomy, Institute for Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.ORCID 0000-0003-1077-1848
Daniel HinzeLAMPseq Diagnostics GmbH, Bonn, Germany.ORCID 0000-0003-2490-6387
Michael HölzelInstitute of Experimental Oncology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID 0000-0003-4048-8824
Iris HelfrichSkin Cancer Unit of the Dermatology Department, Medical Faculty, West German Cancer Center, University Duisburg-Essen, Essen, Germany.ORCID 0000-0001-6150-9570
Dirk SchadendorfSkin Cancer Unit of the Dermatology Department, Medical Faculty, West German Cancer Center, University Duisburg-Essen, Essen, Germany.ORCID 0000-0003-3524-7858
Stefan W SchneiderDepartment of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-4679-7137
Dana WestphalDepartment of Dermatology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0003-4340-0402
Hellmut G AugustinEuropean Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0002-7173-4242
Jacky G GoetzNational Institute of Health and Medical Research (INSERM) UMR_S1109, Tumor Biomechanics, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.ORCID 0000-0003-2842-8116
Yannick SchwabCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Heidelberg, Germany.ORCID 0000-0001-8027-1836
Wolfgang WickNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-6171-634X
Frank WinklerNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0003-4892-6104
German Cancer Research Center · DEInserm · FRUniversität Hamburg · DEUniversity Hospital Bonn · DECarl Zeiss (Germany) · DEEuropean Molecular Biology Laboratory · DEHeidelberg University · DEThe University of Queensland · AUUniversity Hospital Carl Gustav Carus · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crossing the blood-brain barrier is a crucial, rate-limiting step of brain metastasis. Understanding of the mechanisms of cancer cell extravasation from brain microcapillaries is limited as the underlying cellular and molecular processes cannot be adequately investigated using in vitro models and endpoint in vivo experiments. Using ultrastructural and functional imaging, we demonstrate that dynamic changes of activated brain microcapillaries promote the mandatory first steps of brain colonization. Successful extravasation of arrested cancer cells occurred when adjacent capillary endothelial cells (EC) entered into a distinct remodeling process. After extravasation, capillary loops were formed, which was characteristic of aggressive metastatic growth. Upon cancer cell arrest in brain microcapillaries, matrix-metalloprotease 9 (MMP9) was expressed. Inhibition of MMP2/9 and genetic perturbation of MMP9 in cancer cells, but not the host, reduced EC projections, extravasation, and brain metastasis outgrowth. These findings establish an active role of ECs in the process of cancer cell extravasation, facilitated by cross-talk between the two cell types. This extends our understanding of how host cells can contribute to brain metastasis formation and how to prevent it. SIGNIFICANCE: Tracking single extravasating cancer cells using multimodal correlative microscopy uncovers a brain seeding mechanism involving endothelial remodeling driven by cancer cell-derived MMP9, which might enable the development of approaches to prevent brain metastasis. See related commentary by McCarty, p. 1167.

Indexed as

Brain NeoplasmsEndothelium, VascularBrainCell Line, TumorEndothelial CellsHumansMatrix Metalloproteinase 9Matrix Metalloproteinase 9MMP9 protein, human

Identifiers

PMID36652557
PMCPMC7614438
OpenAlexW4317477765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.